Cargando…
Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865969/ https://www.ncbi.nlm.nih.gov/pubmed/27100729 http://dx.doi.org/10.1038/bjc.2016.1 |
_version_ | 1782431861922856960 |
---|---|
author | Verderio, P Bottelli, S Lecchi, M Plebani, M Gariboldi, M Pizzamiglio, S Ciniselli, C M |
author_facet | Verderio, P Bottelli, S Lecchi, M Plebani, M Gariboldi, M Pizzamiglio, S Ciniselli, C M |
author_sort | Verderio, P |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4865969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48659692016-05-24 Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers Verderio, P Bottelli, S Lecchi, M Plebani, M Gariboldi, M Pizzamiglio, S Ciniselli, C M Br J Cancer Letter to the Editor Nature Publishing Group 2016-05-10 2016-04-21 /pmc/articles/PMC4865969/ /pubmed/27100729 http://dx.doi.org/10.1038/bjc.2016.1 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Letter to the Editor Verderio, P Bottelli, S Lecchi, M Plebani, M Gariboldi, M Pizzamiglio, S Ciniselli, C M Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers |
title | Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers |
title_full | Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers |
title_fullStr | Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers |
title_full_unstemmed | Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers |
title_short | Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers |
title_sort | comment on ‘circulating cell-free mirnas as biomarker for triple-negative breast cancer'—methodological challenges in combining mirnas as circulating biomarkers |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865969/ https://www.ncbi.nlm.nih.gov/pubmed/27100729 http://dx.doi.org/10.1038/bjc.2016.1 |
work_keys_str_mv | AT verderiop commentoncirculatingcellfreemirnasasbiomarkerfortriplenegativebreastcancermethodologicalchallengesincombiningmirnasascirculatingbiomarkers AT bottellis commentoncirculatingcellfreemirnasasbiomarkerfortriplenegativebreastcancermethodologicalchallengesincombiningmirnasascirculatingbiomarkers AT lecchim commentoncirculatingcellfreemirnasasbiomarkerfortriplenegativebreastcancermethodologicalchallengesincombiningmirnasascirculatingbiomarkers AT plebanim commentoncirculatingcellfreemirnasasbiomarkerfortriplenegativebreastcancermethodologicalchallengesincombiningmirnasascirculatingbiomarkers AT gariboldim commentoncirculatingcellfreemirnasasbiomarkerfortriplenegativebreastcancermethodologicalchallengesincombiningmirnasascirculatingbiomarkers AT pizzamiglios commentoncirculatingcellfreemirnasasbiomarkerfortriplenegativebreastcancermethodologicalchallengesincombiningmirnasascirculatingbiomarkers AT cinisellicm commentoncirculatingcellfreemirnasasbiomarkerfortriplenegativebreastcancermethodologicalchallengesincombiningmirnasascirculatingbiomarkers |